Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb:28:311-315.
doi: 10.1016/j.ebiom.2018.01.015. Epub 2018 Jan 31.

Disconnect Between Genes Associated With Ischemic Heart Disease and Targets of Ischemic Heart Disease Treatments

C M Schooling  1 , J V Huang  2 , J V Zhao  2 , M K Kwok  2 , S L Au Yeung  2 , S L Lin  2
Affiliations

Disconnect Between Genes Associated With Ischemic Heart Disease and Targets of Ischemic Heart Disease Treatments

C M Schooling et al. EBioMedicine. 2018 Feb.

Abstract

Background: Development of pharmacological treatments to mitigate ischemic heart disease (IHD) has encompassed disappointing results and expensive failures, which has discouraged investment in new approaches to prevention and control. New treatments are most likely to be successful if they act on genetically validated targets. We assessed whether existing pharmacological treatments for IHD reduction are acting on genetically validated targets and whether all such targets for IHD are currently being exploited.

Methods: Genes associated with IHD were obtained from the loci of single nucleotide polymorphisms reported in either of two recent genome wide association studies supplemented by a gene-based analysis (accounting for linkage disequilibrium) of CARDIoGRAMplusC4D 1000 Genomes, a large IHD case (n=60,801)-control (n=123,504) study. Treatments targeting the products of these IHD genes and genes with products targeted by current IHD treatments were obtained from Kyoto Encyclopedia of Genes and Genomes and Drugbank. Cohen's kappa was used to assess agreement.

Results: We identified 173 autosomal genes associated with IHD and 236 autosomal genes with products targeted by current IHD treatments, only 8 genes (PCSK9, EDNRA, PLG, LPL, CXCL12, LRP1, CETP and ADORA2A) overlapped, i.e. were both associated with IHD and had products targeted by current IHD treatments. The Cohen's kappa was 0.03. Interventions related to another 29 IHD genes exist, including dietary factors, environmental exposures and existing treatments for other indications.

Conclusions: Closer alignment of IHD treatments with genetically validated physiological targets may represent a major opportunity for combating a leading cause of global morbidity and mortality through repurposing existing interventions.

Keywords: Gene; Ischemic heart disease; Treatment.

PubMed Disclaimer

References

    1. Ables G.P., Johnson J.E. Pleiotropic responses to methionine restriction. Exp. Gerontol. 2017;94:83–88. - PubMed
    1. Anand I., Chandrashekhan Y., De Giuli F., Pasini E., Mazzoletti A., Confortini R. Acute and chronic effects of propionyl-l-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure. Cardiovasc. Drugs Ther. 1998;12(3):291–299. - PubMed
    1. Angelova P., Momchilova A., Petkova D., Staneva G., Pankov R., Kamenov Z. Testosterone replacement therapy improves erythrocyte membrane lipid composition in hypogonadal men. Aging Male. 2012;15(3):173–179. - PubMed
    1. Au Yeung S.L., Lin S.L., Lam H.S., Schooling C.M. Effect of l-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine on ischemic heart disease risk: a mendelian randomization study. Am. Heart J. 2016;182:54–61. - PubMed
    1. Bacanu S.A. On optimal gene-based analysis of genome scans. Genet. Epidemiol. 2012;36(4):333–339. - PubMed

MeSH terms